XDH and hyperuricemia: It should be especially noted that FEB, a novel and selective xanthine oxidase inhibitor, was selected as a positive control drug in this study because FEB exerted dual effects of reducing SUA and regulating the gut microbiome in hyperuricemia (Pascart and Liote, 2019).